Marksans Pharma informs about updates

19 Nov 2025 Evaluate

Marksans Pharma has informed about the final approval of the Company’s wholly owned subsidiary Marksans Pharma Inc.’s Abbreviated New Drug Application (ANDA) for Loperamide Hydrochloride Tablets USP, 2 mg (OTC). This product is bioequivalent to the reference listed drug (RLD), Imodium A-D Tablets, 2mg, of Kenvue Brands LLC (Kenvue) NDA - 019860. Loperamide Hydrochloride is an anti-diarrheal medication used to control symptoms of acute and chronic diarrhea.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

172.30 -0.65 (-0.38%)
12-Mar-2026 11:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1825.60
Dr. Reddys Lab 1319.95
Cipla 1335.80
Zydus Lifesciences 925.45
Lupin 2336.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×